Authors: WINCHELL GA MCCREA JB CARIDES A KUSMA SE CHIOU R DEUTSCH P YEH KC WALDMAN S BJORNSSON TD

Citation: Ga. Winchell et al., PHARMACOKINETIC INTERACTION BETWEEN INDINAVIR AND RIFABUTIN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 66-66

Authors: SCHWARTZ JI VANHECKEN A DESCHEPPER PJ DELEPELEIRE I LASSETER KC SHAMBLEN EC WINCHELL GA CONSTANZER ML CHAVEZ CM WANG DZ EBEL DL JUSTICE SJ GERTZ BJ

Citation: Ji. Schwartz et al., EFFECT OF MK-386, A NOVEL INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, ALONE AND IN COMBINATION WITH FINASTERIDE, ON SERUM DIHYDROTESTOSTERONE CONCENTRATIONS IN MEN, The Journal of clinical endocrinology and metabolism, 81(8), 1996, pp. 2942-2947

Authors: VANHECKEN A DEPRE M SCHWARTZ JI TJANDRAMAGA TB WINCHELL GA DELEPELEIRE I NG J DESCHEPPER PJ

Citation: A. Vanhecken et al., PLASMA-CONCENTRATIONS AND EFFECT ON TESTOSTERONE-METABOLISM AFTER SINGLE DOSES OF MK-0434, A STEROID-5 ALPHA-REDUCTASE INHIBITOR, IN HEALTHY-SUBJECTS, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 123-126

Authors: WINCHELL GA GREGOIRE S TAYLOR AM HEGLAND J HUNNINGHAKE DB

Citation: Ga. Winchell et al., FINASTERIDE, A STEROID 5-ALPHA-REDUCTASE INHIBITOR, DOES NOT AFFECT THE OXIDATIVE-METABOLISM OF ANTIPYRINE, Journal of clinical pharmacology, 33(10), 1993, pp. 967-970